Methyl 3-(2-amino-4-chlorophenyl)prop-2-enoate | 150097-70-4

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: Methyl 3-(2-amino-4-chlorophenyl)prop-2-enoate
• CAS: 150097-70-4
• 化学式: C₁₀H₁₀ClNO₂
• 分子量: 211.648
• InChiKey: VHCSJCFEYXNKHF-UHFFFAOYSA-N

物化性质

• 熔点：
  115-121 °C(Solv: ethyl acetate (141-78-6); heptane (142-82-5))
• 沸点：
  360.1±32.0 °C(Predicted)
• 密度：
  1.285±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  52.3
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  Methyl 3-(2-amino-4-chlorophenyl)prop-2-enoate 在 吡啶 、 potassium carbonate 、 sodium hydroxide 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 、 丙酮 为溶剂， 反应 56.0h， 生成 [6-chloro-2-(5,6,7,8-tetrahydroisoquinolin-3-ylcarbonyl)-1H-indol-3-yl]acetic acid
  参考文献：
  名称：

  Novel acid-type cyclooxygenase-2 inhibitors: Design, synthesis, and structure–activity relationship for anti-inflammatory drug

  摘要：

  Cyclooxygenase (COX) is a key rate-limiting enzyme for prostaglandin (PG) production cascades in the human body. The mechanisms of both the anti-inflammation effects and the side-effects of traditional COX inhibitors are associated with the existence of two COX isoforms. Thus while COX-1 is predominantly expressed ubiquitously and constitutively, and it serves a housekeeping role in processes such as gastrointestinal (GI) mucosa protection, COX-2 is absent or exhibits a low level of expression in most tissues, and is highly upregulated in response to endotoxin, virus, inflammatory or tissue-injury stimuli/signals, and tumour promoter in the various types of organs, tissues, and cells. Furthermore, COX-2 contribution to PGE(2) and PGI(2) production evokes and sustains systemic or peripheral inflammatory disease, but it is not involved in the COX-1-mediated GI tract events. Also, hypersensitivity of aspirin owing to its inhibitory action against COX-1 is a significant concern clinically. Consequently, highly selective COX-2 inhibitors have been needed for the treatment of inflammatory- and inflammation related-diseases that include pyrexia, inflammation, pain, rheumatoid arthritis, osteoarthritis, and cancers. In this study, a series of novel [2-{[(4-substituted or 4,5-disubstituted)-pyridin-2-yl]carbonyl}-(5- or 6-substituted or 5,6-disubstituted)-1H-indol-3-yl]acetic acid analogues was designed, synthesized, and evaluated to identify potent and selective COX-2 inhibitors as potential agents against inflammatory diseases. As significant findings, the present study clarified unique structure activity relationship of the analogues toward potent and selective COX-2 inhibition in vitro, and identified 2-{6-fluoro-2-[4-methyl-2-pridinyl)carbonyl]-1H-indol-3-yl}acetic acid as a potent and selective COX-2 inhibitor in vitro that demonstrated orally potent anti-inflammation efficacy against carrageenan-induced oedema formation in the foot of SPF/VAF male SD rats as a peripheral inflammation model in vivo. (C) 2012 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2012.01.053
• 作为产物：
  描述：

  4-氯-2-硝基苯甲醛 在 铁粉 、 氯化铵 作用下， 以 乙醇 、 水 、 甲苯 为溶剂， 反应 6.0h， 生成 Methyl 3-(2-amino-4-chlorophenyl)prop-2-enoate
  参考文献：
  名称：

  Novel acid-type cyclooxygenase-2 inhibitors: Design, synthesis, and structure–activity relationship for anti-inflammatory drug

  摘要：

  Cyclooxygenase (COX) is a key rate-limiting enzyme for prostaglandin (PG) production cascades in the human body. The mechanisms of both the anti-inflammation effects and the side-effects of traditional COX inhibitors are associated with the existence of two COX isoforms. Thus while COX-1 is predominantly expressed ubiquitously and constitutively, and it serves a housekeeping role in processes such as gastrointestinal (GI) mucosa protection, COX-2 is absent or exhibits a low level of expression in most tissues, and is highly upregulated in response to endotoxin, virus, inflammatory or tissue-injury stimuli/signals, and tumour promoter in the various types of organs, tissues, and cells. Furthermore, COX-2 contribution to PGE(2) and PGI(2) production evokes and sustains systemic or peripheral inflammatory disease, but it is not involved in the COX-1-mediated GI tract events. Also, hypersensitivity of aspirin owing to its inhibitory action against COX-1 is a significant concern clinically. Consequently, highly selective COX-2 inhibitors have been needed for the treatment of inflammatory- and inflammation related-diseases that include pyrexia, inflammation, pain, rheumatoid arthritis, osteoarthritis, and cancers. In this study, a series of novel [2-{[(4-substituted or 4,5-disubstituted)-pyridin-2-yl]carbonyl}-(5- or 6-substituted or 5,6-disubstituted)-1H-indol-3-yl]acetic acid analogues was designed, synthesized, and evaluated to identify potent and selective COX-2 inhibitors as potential agents against inflammatory diseases. As significant findings, the present study clarified unique structure activity relationship of the analogues toward potent and selective COX-2 inhibition in vitro, and identified 2-{6-fluoro-2-[4-methyl-2-pridinyl)carbonyl]-1H-indol-3-yl}acetic acid as a potent and selective COX-2 inhibitor in vitro that demonstrated orally potent anti-inflammation efficacy against carrageenan-induced oedema formation in the foot of SPF/VAF male SD rats as a peripheral inflammation model in vivo. (C) 2012 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2012.01.053

文献信息

• Photoredox Catalysis toward 2-Sulfenylindole Synthesis through a Radical Cascade Process
  作者：Marilia S. Santos、Hugo L. I. Betim、Camila M. Kisukuri、Jose Antonio Campos Delgado、Arlene G. Corrêa、Márcio W. Paixão

  DOI：10.1021/acs.orglett.0c01297

  日期：2020.6.5

  A radical cascade process initiated through visible-light induced thiyl radical coupling with ortho-substituted arylisocianides followed by an intramolecular cyclization and subsequent aromatization to access 2-sulfenylindoles is described. The key thiyl radicals are promptly generated via a hydrogen atom transfer event. The redox-neutral protocol features broad substrate scope, excellent functional

  描述了一种自由基级联过程，该过程通过可见光诱导的噻吩自由基与邻位取代的芳基抗微生物剂偶联，随后的分子内环化和随后的芳构化来获得2-亚硫基吲哚而引发。关键的噻吩基经由氢原子转移事件迅速产生。氧化还原中性方案具有广泛的底物范围，出色的官能团耐受性和温和的反应条件。此外，通过流程增强，连续流变型的实现允许在较短的停留时间内实现平稳的可伸缩性。
• Copper-Catalyzed Dihydroquinolinone Synthesis from Isocyanides and <i>O</i>-Benzoyl Hydroxylamines
  作者：Zhen Yang、Kun Jiang、Ying-Chun Chen、Ye Wei

  DOI：10.1021/acs.joc.9b00262

  日期：2019.3.15

  A copper-catalyzed protocol has been realized for the rapid assembly of dihydroquinolinones from readily accessible isocyanides and O-benzoyl hydroxylamines. The reactions (10 mol % of CuOAc, 10 mol % of dppe, 3 equiv of PhONa, 30 °C) deliver various structurally interesting dihydroquinolinones in moderate to good yields (up to 76%). The reactions may proceed in a cascade manner involving isocyanide

  已经实现了铜催化的方案，用于从容易获得的异氰酸酯和O-苯甲酰基羟胺快速组装二氢喹啉酮。反应（10 mol％的CuOAc，10 mol％的dppe，3当量的PhONa，30°C）以中等至良好的收率（高达76％）提供了各种结构有趣的二氢喹啉酮。反应可能以级联方式进行，包括将异氰酸酯插入N–O键，Mumm型重排和分子内亲核取代。
• N-Heterocyclic carbene (NHC)-catalysed atom economical construction of 2,3-disubstituted indoles
  作者：Battu Harish、Manyam Subbireddy、Surisetti Suresh

  DOI：10.1039/c6cc10292a

  日期：——

  N-Heterocyclic carbene (NHC)-catalysed atom economical synthesis of a wide range of 2-substituted indole-3-acetic acid derivatives has been disclosed.

  揭示了一种N-杂环卡宾（NHC）催化的原子经济合成广泛的2-取代吲哚-3-乙酸衍生物的方法。
• 1-(4-Benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
  申请人：Bollbuck Birgit

  公开号：US20060173004A1

  公开（公告）日：2006-08-03

  A compound of formula (I), or a pharmaceutically acceptable salt or ester thereof, wherein the symbols have meaning as defined, which are antagonists of CCR-1 and which find use pharmaceutically for treatment of diseases and conditions in which CCR-1 is implicated, e.g. inflammatory diseases.

  式(I)的化合物，或其药学上可接受的盐或酯，其中符号的含义如定义所示，它们是CCR-1的拮抗剂，并且在药学上用于治疗CCR-1参与的疾病和情况，例如炎症性疾病。
• Compounds As Ccri Antagonists
  申请人：Heng Richard

  公开号：US20070196270A1

  公开（公告）日：2007-08-23

  A compound of formula I, or a pharmaceutically acceptable salt or ester thereof, wherein the symbols have meaning as defined, which are antagonists of CCR-1 and which find use pharmaceutically for treatment of diseases and conditions in which CCR-1 is implicated, e.g. inflammatory diseases.

  化合物I的公式，或其药学上可接受的盐或酯，其中符号的含义如定义的那样，它们是CCR-1的拮抗剂，并且在药学上用于治疗与CCR-1有关的疾病和症状，例如炎症性疾病。